Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Jul
23
2018
Imported Frozen Vegetables Linked to Deadly Strain of Listeria is Under Investigation Keller and Heckman LLP
Jul
23
2018
TTB Issues Guidance on Transfers of Beer between Breweries of Different Ownership McDermott Will & Emery
Jul
23
2018
The Ninth Circuit Concludes That the Terms of Taco Bell’s On-Premises Meal Periods Comply with California Meal Period Laws Epstein Becker & Green, P.C.
Jul
23
2018
Interval Licensing v. AOL — Judge Plager’s Concurring Dissent
Jul
23
2018
Health Care Policy Newsletter July 16, 2018
Jul
20
2018
Helsinki Chemicals Forum Includes Debate on Nanomaterials Bergeson & Campbell, P.C.
Jul
20
2018
FDA to Issue a Guidance Document Limiting Use of Milk in Plant-Based Beverages Keller and Heckman LLP
Jul
20
2018
CMS Proposes to Reduce Payments for New Drugs under Medicare Part B Mintz
Jul
19
2018
Health-EU Newsletter Includes Editorial on Safety of Nanomaterials in Sunscreens Bergeson & Campbell, P.C.
Jul
19
2018
FDA’s New Biosimilar Action Plan Represents the Next Step for Improving Drug Competition Mintz
Jul
19
2018
Groups Petition FSIS to Change “Product of the USA” Policy Keller and Heckman LLP
Jul
19
2018
Navigating the Legalization of Marijuana in Massachusetts: What Employers Need to Know Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Jul
19
2018
Weingarten Rights Not Violated; Employee Lawfully Terminated for Refusal to Take Drug/Alcohol Test Jackson Lewis P.C.
Jul
19
2018
340B Drug Pricing Program Litigation Update: American Hospital Association, Et Al. v. Azar Sheppard, Mullin, Richter & Hampton LLP
Jul
18
2018
‘Plastics Recyclability’ Definition Developed by Trade Groups Keller and Heckman LLP
Jul
18
2018
California Court Rules Cereals Not Required to Bear Proposition 65 Warnings Keller and Heckman LLP
Jul
18
2018
Court of Appeals Weighs in on 340B Mintz
Jul
18
2018
Pending California Legislation Alert! Senate Bill 937 Seeks to Require California Employers to Provide Lactation Facilities in the Workplace Jackson Lewis P.C.
Jul
16
2018
FDA Warns of Illegal Online Pharmacies Sending Fake FDA Warning Letters Instead of Medicines to Would Be Customers Keller and Heckman LLP
Jul
16
2018
Health Care Policy Newsletter: Week of July 9, 2018
Jul
15
2018
In the Weeds: Navigating the Shifting Federal Regulation of Medical Marijuana K&L Gates
Jul
13
2018
Does FDA Clear Food Packaging Materials? Keller and Heckman LLP
Jul
13
2018
FDA Publishes Proposed Revision to and Extended Compliance Date for Front of Pack Calorie Declaration for Vending Machines Keller and Heckman LLP
Jul
13
2018
Australian Liquor Company may not get Off Scot(ch) Free K&L Gates
Jul
12
2018
Is Judge Kavenaugh an Enemy of Agency “Chevron Deference”?
Jul
12
2018
WADA issue statement to ‘clarify facts’ of the UCI decision Squire Patton Boggs (US) LLP
Jul
12
2018
Oklahoma Is the Place to Be . . . Especially for Value-Based Contracting McDermott Will & Emery
Jul
12
2018
Recent Guidance by ONC and SAMHSA Sheds Light on Compliance Requirements for 42 CFR Part 2 Squire Patton Boggs (US) LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins